{"data":{"id":"us-nd/n.d.-cent.-code-23-23.1-01","jurisdiction":"us-nd","citation":"N.D. Cent. Code § 23-23.1-01","heading":"Use of laetrile authorized","body":"No hospital or health facility may interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the North Dakota board of medicine in a hearing conducted pursuant to chapter 28-32.","path":["Title 23 Health And Safety","Chapter 23-23.1 Laetrile"],"source_url":"https://ndlegis.gov/cencode/t23c23-1.pdf","current_through":"2026-07-31T11:12:02","vintage":"","retrieved_at":"2026-09-02T21:04:14Z","sha256":"d7da9ad5d6fc9ef0c2ef1bca9f877c128bf8aec87320d197e73334a27f4e87f4","source_id":"us-nd","stale":true,"prev":"us-nd/n.d.-cent.-code-23-23-04","next":"us-nd/n.d.-cent.-code-23-23.1-02"},"notice":"GroundRules: Original legal text. Not legal advice."}